There are more treatment options for psoriasis patients than ever before, so why do patient reported outcomes still suggest failure to meet patient expectations?
Several novel medications have been approved by the U.S. Food and Drug Administration (FDA) for the treatment of psoriasis in the past 20 years. While these therapies have ushered in an era of improved disease control, patient-reported outcomes still suggest failure to meet treatment goals.
Experts from the International Psoriasis Council (IPC) discussed the goals of psoriasis treatment and barriers to receiving optimal care during a day-long roundtable. Their conclusions were published in Dermatology Therapeutics in March.1
The authors speculated that there may be several factors causing the perceived disparity between treatment capabilities and patient satisfaction, including:
1. Patient-perceived improvement. Physicians use validated objective measures of treatment efficacy such as PASI scores; however, these measures differ with patient-perceived improvement. For example, “some patients have found itch to be most bothersome, while dermatologists reported the location and size of the skin lesions as paramount.”
2. The mild-to-moderate patient population. Another factor is that new therapies tend to focus on advanced disease.
“Part of the problem is that the majority of recent innovation has been targeted to the moderate-to-severe patient population, with little new successful development for those psoriasis patients with mild and moderate disease,” the authors write.
3. Differing treatment goals. The authors also note that patients may have higher goals than their physicians, citing the results of a Japanese study where physician-patient misalignment was present in nearly 70% of surveys conducted.2
Furthermore, the authors state, “many patients are unaware that there is a possibility of attaining 100% clearance over both the short-term and long-term,” and that “this finding again highlights the importance of dermatologists recognizing patient expectations in order to reach clinical goals.”
|Read on: [wp_colorbox_media url=”https://www.dermatologytimes.com/treatments-plaque-psoriasis/patient-satisfaction-psoriasis” type=”iframe” hyperlink=”Patient satisfaction in psoriasis”]|